Predicta Med

Connecting the Dots of Undiagnosed Diseases

Startup

Predicta Med is a Ramat Gan-based startup in the Health Tech & Life Sciences sector, established in 2020. Connecting the Dots of Undiagnosed Diseases . The company has raised a total of $5.5M across 2 funding rounds, currently at the Seed stage. Predicta Med was founded by Shlomit Steinberg-Koch and Benny Getz. Key investors include 4T Ventures. The company has 11-50 employees. Core technologies: Platforms & Interfaces, Software, Artificial Intelligence, Deep Learning, Natural Language Processing.

With $5.5M in total funding, Predicta Med is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Beta. The company holds 1 patent.

$5.5M
Raised
2
Rounds
1
Investors
3
Team
2020
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesDigital HealthcareMedical Decision SupportPlatforms & InterfacesSoftwareArtificial IntelligenceDeep LearningNatural Language Processing
At a Glance
Investors
Founders
In the News

5 articles covered by sources including www.calcalistech.com, www.cedars-sinai.org, www.finsmes.com, www.israel21c.org, www.tech12.co.il.

www.calcalistech.com · Jun 24, 2024
"A CEO has to be a doctor, politician, parent, and economic advisor" | CTech
Read article ↗
Frequently Asked Questions
What does Predicta Med do?

Predicta Med is a platform that enables early detection and intervention selection of autoimmune diseases. Its platform gives healthcare providers an AI-powered method for shortening the diagnostic process of identifying autoimmune diseases and by that could enhance provider’s efficiency, improve treatment effectiveness and patient's care. A process which typically takes more than four years and at least four different doctors can be shortened significantly using the platform. Predicta Med’s deep learning engine aggregates EMR and claims data, and enriches and analyzes this data using state-of-the-art learning techniques. The platform discovers patients at risk of having an autoimmune disease and provides actionable insights to enable optimal intervention.

How much funding has Predicta Med raised?

Predicta Med has raised $5.5M in total funding across 2 rounds. The company is currently at the Seed stage. Key investors include 4T Ventures.

Who founded Predicta Med?

Predicta Med was founded in 2020 by Shlomit Steinberg-Koch (Co-founder & CEO), Benny Getz (Co-Founder & CTO).

What sector is Predicta Med in?

Predicta Med operates in Health Tech & Life Sciences, Digital Healthcare, Medical Decision Support, with core technologies in Platforms & Interfaces, Software, Artificial Intelligence, Deep Learning, Natural Language Processing. Target customers: Healthcare & Life Sciences, Healthcare, Providers.

Where is Predicta Med located?

Predicta Med is based in Tuval St 40, Ramat Gan, 5252247, Israel.

View Full Profile Classic View Website ↗